Shah, Hamid Saeed http://orcid.org/0000-0003-4396-5235
Zaib, Sumera
Sarfraz, Muhammad
Alhadhrami, A.
Ibrahim, Mohamed M.
Mushtaq, Aamir
Usman, Faisal
Ishtiaq, Memoona
Sajjad, Muhammad
Asjad, Hafiz Muhammad Mazhar
Gohar, Umar Farooq
Article History
Received: 29 April 2023
Accepted: 26 July 2023
First Online: 8 August 2023
Declarations
:
: The study design entitled “Fabrication and Evaluation of Anticancer Potential of Eugenol Incorporated Chitosan-Silver Nanocomposites: <i>in vitro</i>, <i>in vivo,</i> and <i>in silico</i> studies” was approved by the research committee on Biosafety and Bioethics (approval number: (235/PEC/22), faculty of pharmacy at Bahauddin Zakariya University Multan (60800), Pakistan. The scientists have been instructed to strictly adhere to guidelines for mice that have previously been authorized by the ethics committee.
: Not applicable.
: Samples of the compounds are available from the authors on reasonable request.
: The authors declare no competing interests.